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Available online 12 June 2010Premature closure of cranial sutures, which serve as growth centers for the skull vault, result in
craniosynostosis. In the mouse posterior frontal (PF) suture closes by endochondral ossiﬁcation, whereas
sagittal (SAG) remain patent life time, although both are neural crest tissue derived. We therefore,
investigated why cranial sutures of same tissue origin adopt a different fate. We demonstrated that closure of
the PF suture is tightly regulated by canonical Wnt signaling, whereas patency of the SAG suture is achieved
by constantly activated canonical Wnt signaling. Importantly, the fate of PF and SAG sutures can be reversed
by manipulating Wnt signaling. Continuous activation of canonical Wnt signaling in the PF suture inhibits
endochondral ossiﬁcation and therefore, suture closure, In contrast, inhibition of canonical Wnt signaling in
the SAG suture, upon treatment with Wnt antagonists results in endochondral ossiﬁcation and suture
closure. Thus, inhibition of canonical Wnt signaling in the SAG suture phenocopies craniosynostosis.
Moreover, mice haploinsufﬁcient for Twist1, a target gene of canonical Wnt signaling which inhibits
chondrogenesis, have sagittal craniosynostosis. We propose that regulation of canonical Wnt signaling is of
crucial importance during the physiological patterning of PF and SAG sutures. Importantly, dysregulation of
this pathway may lead to craniosynostosis.nford, CA 94305-5148, USA.
aker), quarto@unina.it
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The calvarial bones in mammalian organisms are formed by
intramembranous ossiﬁcation of membranes derived from paraxial
mesoderm and cranial neural crest (Jiang et al., 2002). This process is
initiated by condensing mesenchyme cells which form ossiﬁcation
centers. The growth of these centers occurs at their edges, the
osteogenic fronts. When osteogenic fronts approximate each other,
they can either merge to create a single bone or form a suture. In
humans, cranial vault sutures typically form with the interfrontal
(metopic) suture between the frontal bones, the sagittal suture
between the parietal bones, the paired coronal sutures between the
two frontal and two parietal bones, the paired lambdoid sutures
between the supraoccipital and parietal bones, and the squamosal
sutures between the parietal, temporal, and sphenoid bones
(Opperman, 2000). This arrangement is very similar to the arrange-
ment seen in other species such as rabbits, mice, rats and zebraﬁsh
(Opperman, 2000; Quarto and Longaker, 2005; Sahar et al., 2005). Asuture consists of two osteogenic fronts and the interfacing suture
mesenchyme. During later stages of development, the suture
mesenchyme functions as a growth center for the skull vault. Most
cranial sutures remain patent during lifetime (Cohen, 1993). An
explicit exception is the metopic suture in humans, which closes in
the ﬁrst year of life and the posterior frontal suture (PF) in mice,
which closes between 13 and 15 days after birth (Sahar et al., 2005;
Vu et al., 2001). Alterations in the developmental program of the skull
can lead to craniosynostosis, a premature fusion of cranial sutures,
that results in skull deformities (Muenke et al., 1994). Several
mutations in the Fibroblast growth factor receptors (FGFR) 1, 2, and
3, MSX2, EFNB1 and TWIST have been reported to cause forms of
craniosynostosis syndromes (Bellus et al., 1996; Howard et al., 1997;
Jabs et al., 1994, 1993; Twigg et al., 2004; Wieland et al., 2004; Wilkie,
1997), however a pathogenesis for sagittal synostosis, the most
common form, is largely unknown.
We have previously demonstrated that in mice the closure of PF
suture occurs between days 13 and 15 through endochondral
ossiﬁcation (Sahar et al., 2005), and that haploinsufﬁciency of Sox 9,
a master regulator of chondrogenesis (Akiyama et al., 2005; Mori-
Akiyama et al., 2003) in neural crest cranial (NCC)-derived tissues
resulted in impaired PF suture closure (Sahar et al., 2005).
It is remarkable that although both PF and SAG suture mesenchyme
are of neural crest origin only PF suture undergoes to endochondral
923B. Behr et al. / Developmental Biology 344 (2010) 922–940ossiﬁcation. Indeed, our previous study raised the question of why PF
andSAG suturemesenchymeof sameembryonic origin adopt adifferent
fate during the suture development.
In the present study we have investigated the potential molecular
mechanism(s) responsible for the different fate adopted by the
suture mesenchyme during the PF and SAG sutures patterning and
development.
Wnt signaling is essential for many developmental processes
including skeletogenesis. Wnt proteins act on target cells by binding to
Frizzleds (Frps), seven-span transmembrane receptor proteins, and
LRP5/6, single-span transmembrane co-receptor proteins. The Wnt/β-
catenin pathway, commonly referred to as the canonical Wnt-pathway
(Logan and Nusse, 2004; Moon et al., 2002; Nelson and Nusse, 2004) is a
common molecular mechanism underlying speciﬁcation of intramem-
branous and endochondral ossiﬁcation (Karsenty, 2008; Logan and
Nusse, 2004;Macsai et al., 2008). This pathway is essential indetermining
whether a mesenchymal progenitor will become osteoblast or chon-
drocyte regardless of regional locations or ossiﬁcation mechanisms (Day
et al., 2005; Hill et al., 2005; Reinhold et al., 2006; Ten Berge et al., 2008).
Wehave investigated theproﬁle of canonicalWnt signaling in PF and
SAG sutures and tested whether this signaling determines the different
fate of PF and SAG sutures. We observed a dynamic proﬁle of canonical
Wnt signaling in the PF suture characterized by a sharp downregulation
overlappingwith the timing of endochondral ossiﬁcation. In contrast, in
the SAG suture a sustained activation of the canonicalWnt signalingwas
observed. Addition of exogenous Wnt3a to the PF suture induced a
constant activation of Wnt signaling mimicking that of the patent SAG
suture, and led to inhibition of endochondral ossiﬁcation and therefore
suture patency. Conversely, inhibition of the canonical Wnt signaling in
SAG suture by treatment with sFrp1 and DKK1 resulted in ectopic bone
formation in the suturemesenchyme, via endochondral ossiﬁcation and
suture closure. Moreover, Twist1+/- mice exhibited sagittal synostosis.
Thus, our data indicate that a differential modulation of canonical Wnt
signaling in PF and SAG sutures is responsible for their different fate.
Materials and methods
Animals
All experiments using animals were performed in accordance with
Stanford University Animal Care and Use Committee guidelines. CD-1
wild type mice were purchased from Charles River Laboratories Inc.
Axin2lacZ/+ heterozygotic mice, Wnt1Cre/R26R mice and Twist1+/−
were genotyped as previously described (Chen and Behringer, 1995;
Jiang et al., 2002; Yu et al., 2005). Twist1+/− mice were purchased
from Jackson Laboratory, (Bar Harbor, Maine).
Animal surgery
Skin incision was performed above the PF or SAG suture of
anesthetized p4 mice. A 1.5 mm diameter collagen sponge (Helistat,
Integra LifeSciences) was either soaked in 150 ng recombinant mouse
Wnt3a (R&D System) and placed on the PF suture, or soaked with aTable 1
Gene Forward primer
cMyc CTGTTTGAAGGCTGGATTT
CyclinD1 TGGAGCCCCTGAAGAAGAG
Dkk1 AATGTATCACACCAAAGGACAAGAAG
Dkk2 AGGAGCCGGGGGAAACAAGAGA
Dkk3 AGGCCCCGGATGAGTACGAAGATG
sFrp1 CGCCATGACCCCGCCCAATACCA
sFrp2 TCGCTCTTCGCCCCTGTCTGTCTC
Sost CCGGGTGGGATGGGGGTCTT
Twist1 GACCTCGGGGCCCTCCACAC
Wif-1 GCTCTGGAGCATCCTACCTTcombinationof 2 μgof sFrp1and2 μgDKK1 (R&DSystem)andplacedon
the SAG suture. PBS-soaked collagen sponges served as controls for both
sutures. The skin incisionwas then closed and themicewere allowed to
recover. Every other day, the sponge was re-soaked with the
corresponding factor(s) or PBS. Speciﬁcally, we re-opened the skin
incision, localized the sponge and appliedWnt3a or the inhibitors on it.Tissue harvest and processing
Animals (n=7) for each time point were sacriﬁced on the exact
postnatal day (p) based on birth date. The PF and the SAG suture were
harvested as previously described (Sahar et al., 2005).RNA isolation and reverse transcription-PCR analysis
Procedures for RNA isolation and reverse transcription were
previously described (Sahar et al., 2005). PCR reactions were
performed under the following conditions: 94 °C for 5 min, 94 °C for
30 s, annealing at 60 °C for 1 min and 72 °C for 1 min (25–30 cycles).
Gapdh, Sox9, Coll II and Col X primers have been previously described
(Sahar et al., 2005). Other primers are listed in Table 1. For the
densitometry analysis of RT-PCR, bands were scanned and quantiﬁed
by using the ImageJ program 1.36b, (http://rsbweb.nih.gov/ij/). The
densitometry results of each band was normalized to its respective
loading control (Gapdh) and presented as percentage increase. The
results are presented as the mean±SE of four independent experi-
ments. Quantitative real time PCR (QRT-PCR) was performed as
previously described (Sahar et al., 2005). The results are presented as
the mean±SE of the three independent experiments.Histology
For cryo-sections, skulls were harvested ﬁxed with 0.4% PFA
overnight and decalciﬁed in 19% EDTA at 4 °C for the appropriate time.
Following decalciﬁcation, specimens were embedded in optimal
cutting temperature (OCT). For parafﬁn sections, skulls were ﬁxed
in 10% neutral buffered formalin and decalciﬁed as described above.
The entire PF and SAG sutures were cut in 10 μm sections. Every third
slide of each cryo-section was stained with Xgal (Roche). Penta-
chrome staining was performed on one neighboring slide to allow for
a direct comparison between β-galactosidase enzymatic activity and
the speciﬁc region within the suture. For parafﬁn sections, every sixth
slide was stained with Pentachrome to determine the exact region
within the suture. Sections were examined with a Carl Zeiss Axioplan
2 microscope. Images were captured by AxioVision.Whole mount staining
Skulls Alcian blue staining was performed as previously described
(Sahar et al., 2005). For β- galactosidase activity calvaria were ﬁxed
0.2% glutaraldehyde and stained with Xgal overnight at 37 °C.Reverse primer Annealing temp. [°C]
TCGAGGTCATAGTTCCTGTT 60
AAGTGCGTTGTGCGGTAGC 60
GATCTTGGACCAGAAGTGTCTAGCA 60
GAGGACGCCCGCCGACACT 61.2
GGGAGCGGCGCAAGACAAAAG 60.6
CCCCACCCTCACCCCAAGCCACAC 60
CTCGCCGCCCTGCTTCTGTCC 60
GGGGGCCAGGAGTGTGATTTCT 60
GCCGCCTCCGCCCGCAGATT 60
AATCATGTGTAAAGGGGGCC 55
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Antibodies against pan β-catenin (SC-1496, 1:50), Sox9 (SC-
17340, 1:30) and cMyc (SC-788, 1:50) were obtained from Santa Cruz
Biotechnology, active β-catenin clone 8E7 (05-665, 1:50) from
Millipore and Twist1 antibody (NB-110-91359, 1:500) from Novus
Biologicals. Antigen retrieval was performedwith Proteinase K (Roche
Diagnostics) for 20 min. A goat or rabbit biotinylated secondary
antibody followed by the AB reagent and NovaRed were used for
detection according to manufacturer's instructions. For immunohis-
tochemistry using active β-catenin clone 8E7 antibody, a Mouse on
Mouse kit was utilized according to the manufacturer's instructions
(all Vector Laboratories). Goat, Mouse or Rabbit irrelevant IgG
(Calbiochem) used as negative controls, did not detect any staining
(data not shown).Western blot analysis
For Western blot analysis, 30 PF- and SAG suture complexes
harvested from p7, p9 and p15 CD-1 mice were homogenized using a
Pellet Pestle Motor (Kontes) in RIPA buffer. Cell lysates were assayed
for protein concentration by bicinchoninic assay. 50 μg of cell lysates
were electrophoresed on 12% Tris–HCL SDS-PAGE gel (Precast Nupage
gels, InVitrogen) and transferred onto Immobilon-P membrane
(Millipore). Immunoblotting analysis was performed with primary
antibodies against active β-catenin clone 8E7 (# 05-665, Millipore) at
concentration of 0.8 μg/ml., pan β-catenin (SC-1496, dilution at
1:200) and α-tubulin (SC-5286, dilution at 1:400) from Santa Cruz
Biotechnologies. HRP-conjugated anti-mouse antibody (1:10,000),
anti-rabbit antibody (1:10,000) and anti-goat antibody (1:10,000, all
Santa Cruz Biotechnologies) were used as secondary antibodies.
Immunoblotted products were visualized by chemiluminescence
substance (Amersham Biosciences). For the densitometric analysis
of immunoblotting, bands were scanned and quantiﬁed by ImageJ
program (ImageJ 1.41; National Institutes of Health). The densito-
metric results were normalized to their respective loading control
(α-tubulin bands). Active β-catenin was presented as percentage of
total β-catenin.Proliferation index
For the proliferation index, sections were stained with anti-PCNA
antibody according to the manufacturer's protocol (Zymed). Adja-
cent slides were stained with Hematoxylin. In the endocranial suture
area, identical region of interest were cropped and transformed to
the binary mode with the software ImageJ (http://rsbweb.nih.gov/
ij/). Thereafter, particle analysis was performed. The proliferation
index was determined by dividing the total particle area of PCNA
staining by the total particle area of the adjacent Hematoxylin
staining.Fig. 1. Canonical Wnt signaling in PF and SAG sutures. A, Xgal staining of coronal section harv
PF and SAG suture mesenchyme. Dashed lines mark the bone plates. Boxed areas represe
Ob, osteoblast; DM, dura mater. B, Alcian blue and Xgal whole mount staining of PF suture
whereas Xgal staining is present in the entire PF suture, indicating activation of canonical Wn
are noted at p7. From p9 through p13 multiple chondrogenic domains are observed, where
suture. C, Alcian blue staining of SAG sutures. Xgal staining shows a steady enhanced activ
P, posterior. D, Pentachrome and Xgal staining on coronal sections of PF sutures. Pentachro
progress through p15. Xgal staining of the suture mesenchyme (middle column) reveals a su
canonical Wnt signaling is observed. E, Pentachrome and Xgal staining on coronal sections of
continuously present in the SAG suturemesenchyme. F, Immunohistochemistry of active and
blot analysis of active and pan β-catenin performed on PF and SAG suture tissue harvested
suture. Membranes were stripped and subsequently incubated with pan β-catenin and α-tub
equal loading and transfer of the samples. H, histogram values represent the percentage of a
indicate the signiﬁcance levels of the student t-test for expression levels in SAG vs. PF sutuResults
PF and SAG suture mesenchyme is of neural crest tissue origin
The common neural crest tissue origin of PF and SAG suture
mesenchyme (Jiang et al., 2002) was conﬁrmed by Xgal staining of PF
and SAG sutures harvested from p7 Wnt1Cre/R26R. Both suture
mesenchyme stained positively (Fig. 1A).
PF suture closure occurs in absence of canonical Wnt signaling
To investigate for a potential link between the occurrence of
chondrogenesis and the activation of the canonical Wnt signaling in
closing PF suture, we performed whole mount Alcian blue and Xgal
staining on calvaria harvested from Axin2+/− mice in which Xgal
stainingmonitors activation of canonicalWnt signaling (Yu et al., 2005).
We used this reporter mouse expressing Axin2-lacZ where the Axin2
locus is interrupted by a lacZ insert because this mouse is currently
considered an accurate reporter for canonical Wnt activity, as the lacZ
reporter gene is under control of the Axin2 promoter (Lohi et al., 2010;
Ten Berge et al., 2008; Yu et al., 2005). In this context, it must be pointed
out that Axin2 has pivotal function in the canonicalWnt signaling: ﬁrst,
Axin2 participates in degradation of β-catenin; Second, Axin2 is a direct
target of canonical Wnt signaling therefore, during activation of
canonical Wnt signaling Axin2 expression is upregulated. Hence,
Axin2 forms a negative regulatory feedback loop (Jho et al., 2002). The
analysiswas carriedout fromdaysp5 top15 (Fig. 1B)which represented
the timing of PF suture endochondral ossiﬁcation and closure (Sahar et
al., 2005). At day p5, Alcian blue staining did not detect cartilage in the
areaof PF suture,whereas strongXgal stainingwasobserved in themost
anterior part of PF suture as result of activated canonical Wnt signaling.
Initial chondrogenic domains were observed in the PF suture at p7 and
p9. These cartilage domains overlappedwith domains negative for Xgal
staining. The Alcian blue staining was most prominent at day p11 and
decreased by day p13with a complete loss by day p15whichmarks the
timing of PF suture closure (Sahar et al., 2005). Importantly, the Alcian
blueandXgal staining revealed that the chondrogenic domainsdetected
within the closing PF suture tightly overlapped with domains in which
the canonicalWnt signalingwas inactive, as indicatedby the lack of Xgal
staining (Fig. 1B). This observation suggested that activation of Wnt
signaling did not occur in the chondrogenic domains of the PF suture. In
sharp contrast, Xgal staining performed on SAG sutures revealed that
the canonicalWnt signalingwas continuously activated along thewhole
suture (Fig. 1C).Moreover, in the SAG suture theXgal stainingwasmore
intense compared to that detected in the PF suture. Therefore, this
analysis revealed that in the patent SAG suture therewas a constant and
enhanced activation of the canonical Wnt-pathway, whereas in the
closing PF suture the canonical Wnt signaling was timely and tightly
regulated.
This observation prompted us to investigate the presence of active
canonical Wnt signaling in closing PF versus patent SAG sutures
more in detail. To this aim, Xgal staining was performed on coronalested fromWnt1Cre/R26Rmice calvaria indicate the common neural crest origin of the
nt the suture mesenchyme. Abbreviations: Pc, pericranium; SM, suture mesenchyme;
s harvested from Axin2+/− mice. At p5, Alcian blue staining does not detect cartilage,
t signaling. Chondrogenic domains (asterisks), corresponding to Xgal negative domains,
as Xgal staining is absent. At p15, chondrogenic domains are no longer noted in the PF
ation of Wnt signaling along the SAG suture mesenchyme. Abbreviations: A, anterior;
me staining of PF suture (left column). Areas of chondrogenesis are present at p9 and
bstantial activation of canonical Wnt signaling at day p5. From day p7 less activation of
SAG sutures. Asterisks depict remnants of the transient cartilage anlagen. Xgal activity is
pan β-catenin in the PF and SAG sutures. Arrowheads indicate positive cells. G, Western
at days p7, p9 and p15 shows higher amounts of both, active and pan β-catenin in SAG
ulin antibody to assess for the total amount of endogenous β-catenin and to control for
ctive β-catenin on total β-catenin. α-Tubulin is a loading control. Asterisks in the graph
res: *=pb0.005.
925B. Behr et al. / Developmental Biology 344 (2010) 922–940sections obtained from PF and SAG sutures at different time points. In
parallel, Pentachrome staining was used to monitor the endochondral
ossiﬁcation and closure of the PF suture (Fig. 1D). Starting from day
p1, Xgal staining was observed in the suture mesenchyme. At day p5,
more Xgal positive cells were observed in the suture mesenchyme. Of
note, these two time points correspond to the mesenchymal pre-
condensation proceeding the chondrogenic differentiation (Sahar
et al., 2005). Less intense Xgal staining was detected at day p7.Pentachrome staining did not reveal yet cartilage formation in the
suture mesenchyme at these time points. Thus, cells that stained
positive for Xgal were negative for cartilage. By day 9, the Xgal
staining sharply decreased in the suture mesenchyme, while cartilage
formation was noticed (blue staining). As chondrogenesis progressed
the canonical Wnt signaling was completely inhibited as revealed
by the lack of Xgal staining among the cells of the PF suture
mesenchyme. A few Xgal positive cells corresponding to hypertrophic
}Fig. 1 (continued).
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observed in the bone plates surrounding the suture. Xgal staining was
not detectable in the suture at p15 and thereafter.
In contrast, the patent SAG suture showed an intense Xgal staining
from p1 to p25 (Fig. 1E). Moreover, remnants of the transient calvarial
cartilage anlagen were observed caudal of the SAG suture mesen-
chyme (Holmbeck et al., 2003). As expected, the SAG suture remained
patent throughout the analysis, and no signs of cartilage formation
within the suture mesenchyme were found (Fig. 1E). These results
strongly indicated that the canonical Wnt signaling is tightly
regulated in the closing PF suture and that the onset on endochondral
ossiﬁcation is marked by a dramatic downregulation of this signaling.
In contrast, the canonical Wnt signaling remains strongly activated
overtime in the patent SAG suture. It must be pointed out that in thecourse of our study we also performed a quantitative PCR analysis of
three downstream target genes of canonical Wnt signaling, cMyc,
cyclin D1 and axin2, to further verify the activation pattern of signaling
in PF and SAG sutures harvested from CD-1 mice. The data obtained
from this additional analysis (Supplemental Fig. 1) correlated with
Xgal staining pattern obtained on Axin2+/−mice, therefore validating
the transgenic reporter mouse.
Differences in activation of canonical Wnt signaling between the
PF and SAG suture were further conﬁrmed by immunohistochem-
istry for active β-catenin and pan β-catenin. Immunohistochemis-
try for active β-catenin revealed nuclear staining at p7 in the PF
suture mesenchyme, whereas no nuclear staining was detectable at
p9 and p15. In contrast, intense β-catenin nuclear staining was
observed in mesenchymal cells of SAG suture at p7, p9 and p15
}Fig. 1 (continued).
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sutures. Additionally, immunohistochemistry for pan β-catenin on
adjacent sections detected higher levels of β-catenin in SAG suture.
In order to further validate the immunohistochemistry data, we
performed a Western blot analysis of PF and SAG suture complexes
(Fig. 1G). Intense immuno-reactive bands for both, active β-catenin
and pan β-catenin were detected in SAG suture compared to
PF suture. Densitometric analysis indicated signiﬁcantly more active
β-catenin in SAG sutures (Fig. 1H).PF and SAG sutures are endowed with different threshold levels of
Wnt antagonists
Wnt signaling is tightly controlled by several groups of antagonists
that interfere either with receptor–ligand binding or with intracellu-lar signaling (Ling et al., 2009; Logan and Nusse, 2004; Macsai et al.,
2008; Niehrs, 2006).
The sharp difference in the activation of canonical Wnt signaling
between PF and SAG sutures is suggestive for the presence of
Wnt inhibitors in the PF suture and lack of them in the SAG suture.
To investigate this possibility we performed a detailed gene
expression analysis for several Wnt antagonists on both PF and SAG
suture. As revealed by RT-PCR analysis (Figs. 2A–G) several Wnt
inhibitors were found to be upregulated in the PF suture. Starting with
the soluble Frizzled (sFrps) family members we observed higher
expression of these genes exclusively in the PF suture. These
ﬁndings were paralleled by family members of Dkk Wnt inhibitors
and ﬁnally, WIF and Sclerostin (Sost), other inhibitors of Wnt
signaling. Quantitative real time PCR analysis further validated
the expression proﬁle of the inhibitors analyzed above (data not
shown).
}Fig. 1 (continued).
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threshold levels of Wnt inhibitors during the timing of patterning and
closure.
These results suggested that the presence of high levels of Wnt
inhibitors in thePFmayberesponsible for the inactivationof canonicalWnt
signaling during the patterning and closure of PF suture. On the contrary,
the markedly decreased expression of inhibitors in the SAG suture allows
the continuous activation of canonical Wnt signaling in this suture.
Wnt3a treatment activates the canonical Wnt signaling in PF suture
The above results demonstrated that during the patterning of PF
and SAG suture, a differential activation of the canonical Wnt
signaling occurs probably due to different threshold levels of Wnt
inhibitors. These observations led us to speculate that the canonical
Wnt signaling might control the suture fate. In order to verify our
hypothesis, we testedwhether continuous application of recombinant
Wnt3a protein on the PF suture could induce a prolonged activation of
canonical Wnt signaling and therefore divert the cell-fate of the PF
suture mesenchyme. This experiment was initially performed onFig. 2. PF and SAG suture are endowedwith different threshold levels ofWnt antagonists. A–G
PF suture. −rt is a negative control for the reverse transcription reaction Histograms repre
program, the relative intensities of bands were normalized to their respective loading contheterozygotic Axin2mice in order to test the proper activation of Wnt
signaling by exogenous Wnt3a protein. The treatment was started at
day p4 and continued until day p14, in order to cover the timing of PF
suture endochondral ossiﬁcation and closure. At p8, a time point
when the canonicalWnt signaling is physiologically downregulated in
the PF suture, no Xgal staining was observed in the untreated PF
suture (Fig. 3A, top panel) and very few positive cells were present in
the PF suture treated with collagen alone (Fig. 3A, middle panel).
Treatment withWnt3a at a concentration of 150 ng strongly activated
the canonical Wnt signaling in the PF suture as indicated by Xgal
staining (Fig. 3A, bottom panel), which validated the successful
release of Wnt3a. The Wnt3a treated suture mesenchyme was
widened, with a large population of Xgal positive cells (Fig. 3A,
bottom panel). Of note, in both controls the PF suture had a normal
pattern. To further validate the activation of canonical Wnt signaling
in PF suture mesenchyme upon Wnt3a treatment, we performed
immunohistochemistry for cMyc, a downstream target of the
canonical Wnt signaling. At p6, i.e. two days after initiation of the
treatment, differences in cMyc immunostaining could be already
detected between the untreated and treated sutures, however at p8,, RT-PCR analysis ofWnt antagonists shows higher threshold levels ofWnt inhibitors in
sent the densitometric analysis of RT-PCR products performed using Image J software
rol (Gapdh) and set as 100%.
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detected in the mesenchyme of Wnt3a treated PF suture compared to
the controls, though here a constant baseline activity was also
detected (Fig. 3B). In both controls, cMyc positive cells could be
predominantly found caudal of the chondrogenic domains, the
chondrogenic domains themselves did not reveal major staining,
thereby conﬁrming the Xgal data previously obtained (Fig. 1D).
Additionally, RT-PCR analysis of the Wnt signaling target gene cMyc
further conﬁrmed the activation of canonical Wnt signaling in Wnt3a
treated PF suture (see Fig. 4B).Constitutive activation of canonical Wnt signaling in the PF suture
inhibits the expression of Sox9 gene
Several lines of evidence emerging from previous studies
suggested that canonical Wnt signaling inhibits chondrogenesisFig. 3. Effect ofWnt3a treatment on PF suture. A, Xgal staining of untreated andWnt3a treate
the canonical Wnt signaling in Wnt3a treated PF suture than controls. Wnt3a treated PF sutu
positive cells are predominantly found caudal of the chondrogenic domain on coronal sect
suture, at days p6 and p8. The presence of cartilage (blue) is validated by Pentachrome staby re-specifying progenitors cells from a chondrogenic towards a
connective tissue fate. Recently, Ten Berge and colleagues
demonstrated that Wnt3a inhibits chondrogenic differentiation
via repression of Sox9 gene (Ten Berge et al., 2008). Immunohis-
tochemistry analysis performed with speciﬁc anti-Sox9 antibody
revealed positive cells in suture mesenchyme of both controls
(Fig. 4A). In contrast, PF suture treated with exogenous Wnt3a
protein showed a dramatic decrease in nuclear Sox9 staining
within cells of suture mesenchyme at day p7 and p9. RT-PCR
analysis conﬁrmed the downregulation of Sox9 upon Wnt3a
treatment. The Sox9 downregulation was paralleled by upregula-
tion of the canonical Wnt signaling target cMyc as result of
efﬁcient activation of the signaling (Figs. 4B and C). Of note, cMyc
expression levels were not entirely downregulated in control PF
sutures at p9 or p15, which might be due its activation and/or
stabilization via other signaling pathways (Palomero et al., 2006;
Weng et al., 2006) (Sears, 2004).d PF sutures harvested from p8 Axin2+/−mice. Xgal staining reveals higher activation of
re is widened. B, cMyc immunohistochemistry reveals staining in controls, where cMyc
ions. PF suture shows an intense staining in the suture mesenchyme of Wnt3a treated
ining (far right column).
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disrupts the proper patterning and closure of the suture
The inhibition of Sox9 observed in PF suture uponWnt3a treatment
led us to predict that treated PF sutures may fail to close. A close
morphometric analysis of theWnt3a treated PF suture revealed distinct
changes in the suture morphology (Fig. 5A). At p6, two days after the
beginning of treatment, no obvious differences in the suture morphol-
ogieswere observed.However, at p8when chondrogenesis began in theFig. 4. Constitutive activation of canonical Wnt signaling in the PF suture inhibits the expres
nuclear staining is observed at p7, andmore intensely at p9 in the PF suturemesenchyme con
day p15, Sox9 staining fades. B, RT-PCR analysis shows downregulation of Sox9 and upregu
analysis of RT-PCR products.PF suture controls, Pentachrome staining did not detect any cartilage in
the Wnt3a treated suture. Moreover, both, the ecto and endocranial
layers werewidely separated and the typical PF suturemorphologywas
severely impaired due to the overgrowth and lack of differentiation of
suture mesenchyme. The distance between the osteogenic fronts of the
endocranial layerswasapproximately8-fold larger in theWnt3a treated
PF suture compared to controls. At p16, the control PF sutures closed,
while the Wnt3a treated suture remained patent. Initially, these
experimentswere carried out onAxin2+/−mice, to assess the biologicalsion of Sox9 gene. A, Sox9 immunohistochemistry on PF sutures of Axin2+/−mice. Sox9
trols. InWnt3a treated PF sutures, no staining is observed in the suture mesenchyme. By
lation of cMyc in Wnt3a treated PF sutures. C, the graph represents the densitometric
932 B. Behr et al. / Developmental Biology 344 (2010) 922–940activity of addedWnt3a protein. Although the Axin2 heterozygotic mice
have normal phenotype (Yu et al., 2005) we wanted to rule out the
possibility that the outcoming results were due to the genetic
background. Therefore, we repeated the experiments on wild type
CD-1 mice. Similar results were obtained when PF suture of CD-1 mice
were treated with Wnt3a (Fig. 5B).Fig. 5. Continuous activation of canonical Wnt signaling in the PF suture disrupts the pro
harvested from Axin2+/−mice. At p6, no obvious differences are visible among all three grou
Green bars mark the distance between the two osteogenic fronts. InWnt3a treated sutures, a
arrowhead), whereas Wnt3a treated sutures are patent (black double arrow). B, Pentachrom
similar results as above. C and D PCNA immunohistochemistry onWnt3a treated PF sutures h
of the proliferation rates.Wnt3a treatment induces suture mesenchyme proliferation
The widening of PF sutures upon treatment with Wnt3a indicated
that Wnt3a triggered proliferation of suture mesenchymal cells. As
shown in Fig. 5C, in Axin2+/− mice, PCNA staining revealed very few
proliferating cells in both controls (0.5% in untreated control and 6.7%per patterning and closure. A, Pentachrome staining on coronal sections of PF suture
ps. At p8, an overgrowth of suture mesenchyme is observed inWnt3a treated PF suture.
reas of chondrogenesis are missing. At p16, both control sutures are closed (black single
e staining on coronal sections of PF suture harvested from CD-1 wild type mice shows
arvested from Axin2+/− and CD-1 wild typemice. Histograms represent a quantiﬁcation
}Fig. 5 (continued).
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proliferating cells (positive cell rate of 50%) was found in the
mesenchyme of Wnt3a treated PF suture. PCNA immunostaining
was likewise performed on Wnt3a treated PF sutures of CD-1 wild
type mice and their corresponding controls at day p8 (Fig. 5D). In
controls, positive cells were 9.8% and 16.7% respectively, whereas in
the Wnt3a treated PF suture 67.3% of the cells were PCNA positive.
These results demonstrated that Wnt3a triggered proliferation of
suture mesenchymal cells diverting them from chondrogenesis.
Inhibition of the canonical Wnt-pathway in the SAG suture results in
suture closure
The ﬁnding that constant application of Wnt3a to the PF suture
mimics the fate of SAG suture, led us to investigate effects of inhibiting
Wnt signaling in the SAG suture. We asked whether inhibition of
canonical Wnt signaling could inﬂuence the fate of SAG suture and
make it PF-like. To ensure a proper inhibition of the LRP5/6 and
Frizzled receptor, as well as sequestration of Wnt ligands in the
extracellular space, recombinant DKK1 and sFrp1 proteins were
applied in combination. Both controls showed strong Xgal staining in
the suturemesenchyme. In contrast, constant application of DKK1 and
sFrp1 inhibited canonical Wnt signaling as indicated by Xgal staining
at p8 (Fig. 6A), which validated a successful release of the inhibitors.
Adjacent slides underwent Pentachrome staining to monitor the
morphology, the potential occurrence of chondrogenesis and suture
closure. Starting from day p10, Pentachrome staining revealed
undifferentiated suture mesenchyme in the control groups, but
areas of chondrogenesis in the suture mesenchyme of SAG suture
treated with inhibitors (Fig. 6B). Furthermore, immunohistochemis-
try performed using a speciﬁc anti-Sox9 antibody detected a strong
nuclear staining for Sox9 protein in the SAG suture mesenchymetreated with inhibitors (Fig. 6C). Several Sox9 positive cells over-
lapped with the corresponding chondrogenic area. Conversely, Sox9
immunostaining did not reveal positive cells in controls. In addition,
RT-PCR indicated upregulation of Sox9 expression in DKK1/sFrp1
treated SAG suture and downregulation of cyclin D1 and cMyc
(Fig. 6D). The occurrence of chondrogenesis in DKK1/sFrp1 treated
SAG suture was conﬁrmed at molecular level by RT-PCR. In DKK1/
sFrp1 treated SAG suture an appropriate temporal expression pattern
of Sox9, Collagen Type II and Type X (Coll II Coll X) was observed, no
chondrogenic markers were detected in controls (Fig. 6E).
Because Twist1, a target of canonical Wnt signaling (Howe et al.,
2003), inhibits chondrogenesis, (Reinhold et al., 2006)we investigated
whether inhibition of canonical Wnt signaling could affect Twist1 in
our system. At p10, Twist1 immunostaining was detected in controls,
but markedly decreased in DKK1/sFrp1 treated SAG sutures (Fig. 6F).
The occurrence of chondrogenesis, and the downregulation of Twist1
in DKK1/sFrp1 treated SAG sutures at p10 raised the question,
whether the SAG suture could eventually close. At d16, marked
differences between the SAG suture treated with inhibitors and their
controls were observed. Pentachrome staining revealed physiological
SAG suture patency in the controls. Conversely, in the SAG treatedwith
inhibitors, suture closure occurred in the caudal mesenchyme, where a
bony bridge formed between the two osteogenic fronts (Fig. 6G). These
data indicated that abrogation of canonical Wnt signaling in the SAG
suture promoted endochondral ossiﬁcation of suture mesenchyme,
therefore phenocopying pathologic fusion/craniosynostosis.
Differential expression of Twist1 in PF and SAG sutures and its role in
suture craniosynostosis
We focused on Twist1, a protein controlling chondrogenesis, to
further elucidate why the NCC-derived mesenchyme of PF suture
Fig. 6. Inhibition of the canonical Wnt signaling in the SAG suture results in suture closure. A, Xgal staining of untreated and DKK1/sFrp1 treated SAG sutures from p8 Axin2+/−mice.
Xgal staining is strong in controls, while absence of Xgal staining is observed in the suture mesenchyme of the SAG suture treated with inhibitors. B, Pentachrome staining of SAG
sutures treated with DKK1/sFrp1 reveals areas of chondrogenesis in the suture mesenchyme at day p10. C, Sox9 immunohistochemistry detects intense nuclear staining in the
mesenchyme of SAG suture treated with DKK1/sFrp1. D, RT-PCR analysis shows upregulation of Sox9 in SAG sutures treated with DKK1/sFrp1 and downregulation of cMyc and
cyclin D1. The graph represents the densitometric analysis of RT-PCR products performed as above. E, RT-PCR analysis of chondrogenic markers. F, Twist1 immunohistochemistry
detects low staining in DKK1/sFrp1 treated SAG suture. G, At day p16, Pentachrome staining reveals closure of the SAG suture treated with inhibitors.
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speculated that Twist1 expression levels in PF and SAG suture might
mirror the different activation levels of the canonical Wnt signaling.
To verify our hypothesis we performed a time course analysis of
Twist1 both at gene and protein levels in PF and SAG wild type
sutures. RT-PCR analysis (Fig. 7A) revealed a distinct Twist1 gene
expression proﬁles between PF and SAG sutures. The PF suture had a
sharpmodulation of Twist1 gene expression, with the highest levels at
day p5 and p7. By day p9 Twist1 expression dramatically down-
regulated, whereas in SAG suture a sustained upregulation of Twist1
gene expression was observed. Similarly, immunohistochemistry
analysis showed high levels of Twist1 protein in the PF suture at p5and p7, followed by a dramatic decrease at p9, when chondrogenesis
physiologically occurs (Fig. 7B). Conversely, intense Twist1 nuclear
staining was observed in the SAG sutures during the entire time
course. The overlapping expression of Twist1 with the activation of
canonical Wnt signaling in SAG suture prompted us to investigate the
fate of this suture in Twist1+/− mice. To this purpose we analyzed
coronal sections of SAG sutures harvested from Twist1+/− haploin-
sufﬁcient mice, due to the fact that homozygotic mice die in-utero. As
shown in Fig. 7C Pentachrome staining detected undifferentiated
suture mesenchyme in wild type sutures, whereas areas of chon-
drogenesis were detected in Twist1+/− SAG suture at p11. By day
p25, partial closure of the Twist1+/− SAG suture with a bony
936 B. Behr et al. / Developmental Biology 344 (2010) 922–940bridge between the overlapping osteogenic fronts was observed
(n=5/7). Thus, our analysis indicated craniosynostosis of SAG suture
in Twist1+/− mice.
Discussion
Why cranial suture mesenchyme of the same embryonic tissue
origin adopts a different fate is an intriguingquestion that prompted our
study. In this paperwe provide evidence for different activation levels ofFig. 7. Differential expression pattern of Twist1 in PF and SAG suture and synostosis of SAG sutu
pattern betweenPF and SAG sutures. B, immunohistochemistry analysis conﬁrms the differentia
staining reveals patent SAG sutures in wild type mice. In contrast Twist1+/− mice show cho
osteogenic fronts with a partial suture closure at p25. D, proposed model: sustained activati
inhibition of canonical Wnt signaling in the PF suture, leads to suture closure Moreover, differe
chondrogenesis, which in turn may affect the fate of PF and SAG sutures.canonical Wnt signaling in the closing PF and the patent SAG sutures.
Importantly, our study indicates that inhibition of canonical Wnt
signaling is necessary for the appropriate timing of chondrogenic
differentiation of PF suturemesenchyme, which eventually results in PF
suture closure. We demonstrate that effective inhibition of enhanced
canonical Wnt signaling in patent SAG suture leads to pathological
closure. Thus, inhibition of canonical Wnt signaling in SAG suture
phenocopies craniosynostosis. These ﬁndings were corroborated by the
identiﬁcation of sagittal synostosis in Twist1+/− mice. The analysis ofre in Twist1+/−mice. A, RT-PCR analysis of Twist1 gene indicates a differential expression
l expressionpattern of Twist1. C, synostosis of SAG suture in Twist1+/−mice. Pentachrome
ndrogenesis in the SAG suture mesenchyme at p11 and a bony bridge between the two
on of canonical Wnt signaling leads to SAG suture patency, whereas attenuation and/or
ntial activation of canonical Wnt signaling triggers different expression of Twist1 gene and
}Fig. 7 (continued).
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cause a partial craniosynostosis with a penetrancy of approximately
70%. Together, these data provide a new framework for understanding
the molecular pathology of SAG suture craniosynostosis and present
canonical Wnt signaling as a candidate in efforts to manipulate
craniosynostosis for experimental and clinical purposes.
Closing PF suture: a Wnt antagonist microenvironment
Analysis of canonical Wnt signaling in PF and SAG sutures has
revealed that this pathway is differentially activated between the twosutures. In the PF suture, canonical Wnt signaling is tightly regulated
during the timing of patterning and closure. Activation of canonical
Wnt signaling was observed at early time points corresponding to the
mesenchymal cell pre-condensation, but with the onset of chondro-
genic differentiation the signaling drastically decreased. Conversely,
in the patent SAG suture canonical Wnt signaling remained activated
continuously.
Secreted Wnt antagonists include Wnt inhibitory factor (WIF1),
secreted FZD-related proteins (sFRPs), Cerberus (Kawano and Kypta,
2003), Dickkopfs (Dkks) (Niehrs, 2006) and Sclerostin (Baron and
Rawadi, 2007; Canalis et al., 2007). These proteins bind Wnts directly
938 B. Behr et al. / Developmental Biology 344 (2010) 922–940(WIF, sFRPs, and Cerberus), bind to FZD receptors (sFRPs and Sost), or
interact directly or indirectly with LRPs (Dkks). Inhibitors like sFRPs
that bind Wnts or FZD receptors have the ability to blunt all Wnt-
activated pathways (Jones and Jomary, 2002), whereas Dkks only
suppress the canonical pathway (Zorn, 2001). Our analysis revealed
that the threshold levels of Wnt antagonists is higher in the closing PF
than patent SAG suture. We therefore believe that they may be
responsible for the tight regulation of canonical Wnt signaling in PF
suture, as well as the development and closure of the PF suture. This
hypothesis is also supported by the ﬁnding that gene expression
analysis of Wnt ligands and receptors, known to play a major role in
osteoblastogenesis and chondrogenesis, did not reveal overtime a
preferential up- and/or -downregulation of these genes between PF
and SAG sutures (data not shown). Cadherins, can also modulate
Wnt signaling. N-cadherin and E-cadherin can directly interact with
β-catenin and may thereby decrease Wnt signaling (Linask et al.,
1997; Nelson and Nusse, 2004; Xu et al., 2002). Moreover, N-cadherin
interacts with axin and LRP5 to negatively regulate the canonical
Wnt /β-catenin signaling (Hay et al., 2009). Notably, our recent study
(Sahar et al., 2010) showed unique modulation of cadherins
expression pattern during PF suture development and closure.
Interestingly, comparative RT-PCR analysis of PF and SAG sutures
has shown unique upregulation of E-cadherin in PF suture undergoing
closure. In addition, the analysis has revealed a unique biphasic
expression of N-cadherin in the PF suture, the ﬁrst phase coinciding
with cellular condensation preceding chondrogenesis followed by a
second phase coinciding with E-cadherin co-expression and suture
closure. These results would suggest that E- and N-cadherins
represent an additional control of inhibition of canonical Wnt
signaling in PF suture.
Continuous activation of canonical Wnt signaling disrupts PF suture
patterning and closure
The regulation of Sox9 in relation to the canonical Wnt signaling
has been demonstrated by the ﬁndings that Wnt effects on
chondrogenic differentiation are Sox dependent (Akiyama et al.,
2005; Day et al., 2005; Hill et al., 2005). Our data indicate that
continuous application of Wnt3a on the PF suture induced a
constitutive activation of canonical Wnt signaling, leading to
simultaneous downregulation of Sox9 and upregulation of cMyc
genes, which in turn abolished the endochondral ossiﬁcation process
and closure of the PF suture. Thus, our study suggests that appropriate
attenuation of Wnt signaling by endogenous inhibitors is essential for
the physiological closure of PF suture. These ﬁndings are comple-
mentary to previous genetic studies that deﬁned appropriate levels of
Wnt/β-catenin signaling for commitment to the chondrogenic
lineage (Day et al., 2005; Gaur et al., 2006; Hill et al., 2005), and to
a recent work showing that Wnt3a treatment maintained limb
mesenchyme in an undifferentiated state by inhibiting Sox-9
expression while upregulating myc expression (Ten Berge et al.,
2008). Therefore, we hypothesize, that the increased mesenchyme
proliferation in Wnt3a treated PF sutures is due to direct mitogenic
effect of exogenous Wnt3a in triggering cell proliferation and
preventing mesenchymal cell to adopt a chondrogenic fate.
As mentioned earlier, detailed histological analysis has well
characterized the fashion and timing of PF suture in mice (Sahar
et al., 2005). In mice the physiological closure of the PF suture is fully
accomplished between days 13–15 postnatally. Surprisingly, Yu and
colleagues in their study on Axin2−/−mice phenotype referred to a PF
(metopic) suture closure occurring at day p17 as a “premature fusion”
(Yu et al., 2005). Moreover, according to their description, Yu and
colleagues stated that the PF (metopic) suture lies between nasal
bones. It must be pointed out that indeed, PF suture lies between
frontal bones instead (Opperman, 2000). In contrast, our preliminary
histological analysis on PF suture of Axin2−/−mice showed that at dayp17 the PF suture was still patent as compared to wild type mice.
Pentachrome staining of serial sections spanning along the entire PF
suture revealed lack of bony tissues between the two osteogenic
fronts of the endochondral plates (data not shown).
Controlled inhibition of canonical Wnt signaling makes SAG suture a
“PF-like suture”
The high threshold levels of Wnt antagonists in the PF suture
suggests that these antagonists may be potential candidate signals
promoting endochondral osteogenesis of PF suture and therefore its
closure. If this is true, can treatment with exogenous Wnt signaling
antagonists regulate differentiation and cell-fate speciﬁcation of SAG
suture mesenchyme? Speciﬁcally, can inhibition of canonical Wnt
signaling make a patent suture becoming a closing suture? Mimicking
the PF suture Wnt antagonists microenvironment by adding Dkk and
sFrp proteins to the SAG suture successfully inhibited canonical Wnt
signaling in SAG suture and simultaneously guided the segregation of
suture mesenchymal cells into chondrocytes. Moreover, inhibition of
the canonical Wnt signaling induced ectopic endochondral bone in
the SAG suture mesenchyme leading to the suture closure. These
results strongly indicate that inhibition of canonical Wnt signaling
within the mesenchyme of a physiologically patent suture, may
represent a permissive condition for craniosynostosis.
A “twisted” feeling between closing PF and patent SAG sutures
In mammals, Twist1 is expressed in cranial neural crest derivatives
and in mesenchymal structures (Gitelman, 1997). The importance of
Twist in craniosynostosis is documented by the fact that mutations in
the TWIST gene cause the Saethre–Chotzen syndrome, an autosomal
dominant craniosynostosis (el Ghouzzi et al., 1997; Yoshida et al.,
2005), which is the second most prevalent genetic craniosynostosis
syndrome. Other studies have also indicated that Twist1 is an
important target of Wnt signaling that contributes to the repression
of chondrogenesis by canonical Wnt signaling (Howe et al., 2003;
Reinhold et al., 2006).
Our study reveals that Twist1 is differentially expressed in PF and
SAG suture possibly as a result of different activation of canonical Wnt
signaling. This hypothesis is supported by a previous study showing
that Wnt3 treatment protein inhibits Twist1 expression in immature
chondrocytes preventing their maturation (Dong et al., 2007).
Furthermore, several reports indicated that Twist1 plays a critical
role in promoting limb development in vivo (Tavares et al., 2001;
Zuniga et al., 2002). In PF suture Twist1 is poorly expressed, whereas
its endogenous levels are high in SAG suture. Intense expression of
Twist1 has been also observed in embryonic SAG suture mesenchyme
(Rice et al., 2000).
Interestingly, our results indicate that upon inhibition of canonical
Wnt signaling in SAG suture, the expression of Twist1 is dramatically
downregulated and the SAG suture closes through endochondral
ossiﬁcation. These data are in agreement with an additional study
showing that delivery of Wnt antagonist Dkk1 suppresses Twist1
expression (He et al., 2009). Furthermore, the occurrence of
chondrogenesis and sagittal synostosis observed in haploinsufﬁcient
Twist1mice strongly supports the concept, that lack of canonical Wnt
signaling in SAG sutures results in sagittal synostosis by potential
suppression of Twist1 gene expression.
Regulation of Wnt signaling and craniosynostosis: new perspectives
By far the most common form of craniosynostosis in humans is the
sagittal synostosis. It occurs in 56% to 58% of all reported craniosy-
nostosis cases (Anderson and Geiger, 1965; Hunter and Rudd, 1976;
Pensler et al., 1996; Shillito and Matson, 1968), however little is
known about its molecular pathogenesis. A molecular diagnosis, i.e.
939B. Behr et al. / Developmental Biology 344 (2010) 922–940the detection of a mutation, can only be made in ∼25% of an entire
craniosynostosis patient population, though these syndromes pre-
dominantly affect the coronal sutures (Morriss-Kay andWilkie, 2005;
Wilkie and Morriss-Kay, 2001). Among these cases, the FGFR3 related
Muenke syndrome is the most common one, followed by the TWIST
related Saethre–Chotzen syndrome (Morriss-Kay and Wilkie, 2005).
Furthermore, there is less evidence for genetic components in isolated
non-syndromic sagittal craniosynostosis cases than the coronal
(Boyadjiev, 2007). Our data demonstrated that activation of canonical
Wnt signaling is a crucial requisite for SAG suture patency. This is
supported by the following observations: ﬁrst, canonical Wnt
signaling is constantly activated in the patent SAG suture and
secondly, inhibition of canonical Wnt signaling by exogenously
added Wnt antagonists leads to SAG suture closure through
endochondral ossiﬁcation.
Several lines of evidence support and corroborate our study.
Interestingly, recent QRT-PCR analysis performed on human calvarial
suture samples revealed that the Wnt antagonist WIF1 was increased
by 10-fold in fused SAG sutures derived from craniosynostosis
patients compared to unfused SAG sutures (Coussens et al., 2008).
Additionally, the microarray data showed a decreased expression of
WIF1 in the unfused sagittal suture compared to the unfused lamboid
suture. Conversely, in the unfused sagittal suture Wnt5a was
increased 5.2 fold as compared to the unfused lamboid suture
(Coussens et al., 2007). Moreover, decreased expression of the
canonical Wnt signaling gene WISP2 and the non-canonical Wnt-
pathway gene Wnt5A were found in fused sagittal sutures (Coussens
et al., 2008). Interestingly, our data indicated that the expression of
Wif1 is higher in the closing PF suture as compared to patent SAG
suture.
Detected mutations in the non-syndromic sagittal synostosis
patients are rare, however a S188L mutation in the Twist Box of the
Twist1 protein was identiﬁed in a patient with isolated sagittal
synostosis (Seto et al., 2007). In our study we found that in the SAG
suture, Twist1 gene expression is upregulated compared to the PF
suture, which mirrors the different canonical Wnt signaling activity of
both sutures. Moreover, we demonstrated that inhibition of Wnt
signaling in the SAG suture by exogenously added Wnt antagonists
leads to downregulation of Twist1 gene expression followed by cranial
suture closure, thus phenocopying SAG suture craniosynostosis. In the
light of our results, it is tempting to speculate that the causative effects
for isolated sagittal synostosis are most likely of epigenetic nature.
Decreased activation of canonical Wnt signaling as well levels of
Twist1 in the sagittal suture might be responsible for the synostosis.
Based on our ﬁndings we propose amodel, in which canonicalWnt
signaling plays a central role in determining the suture fate (Fig. 7D).
Wnt activation results in suture patency, whereas Wnt inhibition
results in ectopic bone formation within the suture mesenchyme and
suture closure. Low levels of endogenous Wnt antagonists would tilt
the balance in favor of canonical Wnt signaling, which could be
sufﬁcient to trigger expression of Twist1 and suture patency. In
contrast, high threshold levels of Wnt antagonists would ﬁnely
regulate and attenuate canonical Wnt signaling in cranial sutures i.e.
PF, thereby inducing the proper suture patterning and closure. These
interesting and plausible scenarios are being further tested in ongoing
studies.
Indeed, understanding the signaling networks that control the
commitment and differentiation of suture mesenchyme cells will not
only expand our basic knowledge of the molecular mechanism of
cranial suture development but will also aid our ability to develop
therapeutic means of intervention in craniosynostosis.
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